Icosapent Ethyl Following Acute Coronary Syndrome: The Reduce-It Trial

Authors

• Neila Sayah
• Deepak L Bhatt
• Michael Miller
• Eliot A Brinton
• Terry A Jacobson
• Steven B Ketchum
• Lixia Jiao
• Armando Lira Pineda
• Ralph T Doyle
• Jean Claude Tardif
• Christie M Ballantyne
• Ph Gabriel Steg

Language

English

Publication Date

4-1-2024

Journal

European Heart Journal

DOI

10.1093/eurheartj/ehad889

PMID

38252107

PMCID

PMC10984562

PubMedCentral® Posted Date

1-22-2024

PubMedCentral® Full Text Version

Post-print

Keywords

Humans, Acute Coronary Syndrome, Cardiovascular Diseases, Eicosapentaenoic Acid, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hypertriglyceridemia, Triglycerides

Published Open-Access

yes

Recommended Citation

Sayah, Neila; Bhatt, Deepak L; Miller, Michael; et al., "Icosapent Ethyl Following Acute Coronary Syndrome: The Reduce-It Trial" (2024). Faculty, Staff and Students Publications. 6692.
https://digitalcommons.library.tmc.edu/baylor_docs/6692